DUBOIS, Pa. (EYT) – State narcotics investigators say a DuBois doctor is facing drug charges after he was suspected of relapsing upon completion of rehabilitation for drug addiction.
According to a criminal complaint filed by the Attorney General’s office, 40-year-old David Girardi, of DuBois, is accused of issuing oxycodone prescriptions to a known female for his personal use.
Girardi waived his preliminary hearing on Friday, December 1, in District Judge Patrick Ford’s office.
The case was transferred to the Clearfield County Court of Common Pleas.
Girardi, who operates a family practice in Brookville, is charged with one misdemeanor count of Procuring Drugs for Self/Other by Fraud.
Girardi is free on $2,500 unsecured bail.
He is scheduled to appear for a formal arraignment at 1:30 p.m., Wednesday, December 27, with F. Cortez Bell III, presiding.
The complaint states that Narcotics Agent Duane Musser used the state’s Drug Monitoring Program to verify there had been eight oxycodone/acetaminophen (Percocet) prescriptions and two hydrocodone/acetaminophen prescriptions authorized by Girardi and filled for a known female between November 30, 2016, and April 25, 2017, for a total of 175 oxycodone/acetaminophen tablets and 50 hydrocodone/acetaminophen tablets.
On September 20, 2017, Agent Musser interviewed the known female, who said Girardi had prescribed Percocet to her between approximately October 2016 and June 2017. She believed she had taken 15 to 20 Percocet tablets during that period and was still in possession of about 30 Percocet tablets, the complaint indicates.
On October 27, 2017, Girardi allegedly told Agent Musser he had taken some of the Percocet that was prescribed for the known female, according to the complaint.
According to court documents, in 2008, Girardi was charged with seven counts of Procuring Drugs for Self/Other by Fraud. After pleading guilty in 2009, he was sentenced to two years probation and was ordered to attend and successfully complete Drug and Alcohol treatment or counseling.
Copyright © 2024 EYT Media Group, Inc. All rights reserved. Any copying, redistribution or retransmission of the contents of this service without the express written consent of EYT Media Group, Inc. is expressly prohibited.
